Close Menu

'Not Dead Yet'

At The New York Times' Prescriptions blog, Andrew Pollack says RNA interference "might not be dead yet." That Alnylam Pharmaceuticals recently announced it had established proof of concept for the efficacy of an RNAi-based drug in a phase 1 clinical trial "at least points to the possibility that the approach can be used in people," Pollack says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.